Potential Role of CREM in Diabetes‐Associated Testicular Dysfunction: Current Evidence and Future Perspectives

ABSTRACT Background Type 2 diabetes mellitus (T2D) is a growing metabolic disorder affecting all age groups and is linked to testiculopathy, a key contributor to male infertility. Testiculopathy disrupts spermatogenesis and the sperm microenvironment, with the cyclic adenosine monophosphate (cAMP) r...

Full description

Saved in:
Bibliographic Details
Main Authors: Olabimpe Caroline Badejogbin, Oyedayo Phillips Akano, Oluwafisayo Elizabeth Boluwatife Julius, Mary Olaoluwa Agunloye, Makinde Vincent Olubiyi, Ojichukwuka Ebere Chijioke‐Agu, Matthew Agene Obekpa, Adesina Paul Arikawe, Kehinde Samuel Olaniyi
Format: Article
Language:English
Published: Wiley 2025-01-01
Series:Reproductive Medicine and Biology
Subjects:
Online Access:https://doi.org/10.1002/rmb2.12661
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849233376315179008
author Olabimpe Caroline Badejogbin
Oyedayo Phillips Akano
Oluwafisayo Elizabeth Boluwatife Julius
Mary Olaoluwa Agunloye
Makinde Vincent Olubiyi
Ojichukwuka Ebere Chijioke‐Agu
Matthew Agene Obekpa
Adesina Paul Arikawe
Kehinde Samuel Olaniyi
author_facet Olabimpe Caroline Badejogbin
Oyedayo Phillips Akano
Oluwafisayo Elizabeth Boluwatife Julius
Mary Olaoluwa Agunloye
Makinde Vincent Olubiyi
Ojichukwuka Ebere Chijioke‐Agu
Matthew Agene Obekpa
Adesina Paul Arikawe
Kehinde Samuel Olaniyi
author_sort Olabimpe Caroline Badejogbin
collection DOAJ
description ABSTRACT Background Type 2 diabetes mellitus (T2D) is a growing metabolic disorder affecting all age groups and is linked to testiculopathy, a key contributor to male infertility. Testiculopathy disrupts spermatogenesis and the sperm microenvironment, with the cyclic adenosine monophosphate (cAMP) response element modulator (CREM) playing a pivotal role in testicular function. Understanding the interplay between T2D and CREM dysregulation is essential for developing targeted therapies for diabetic testicular dysfunction. Methods A systematic review of PubMed, Web of Science, Scopus, and Google Scholar was conducted to identify peer‐reviewed studies, both preclinical and clinical, that explored CREM's role in diabetes‐induced testicular dysfunction. Extracted data focused on CREM expression, oxidative stress, apoptosis, and spermatogenic impairment in diabetic models. Main Findings Research from studies on diabetic patients and animal models highlights the detrimental effects of diabetes on the reproductive system, including hypothalamic–pituitary–testicular (HPT) axis dysregulation. CREM regulates spermatogenic gene expression, influenced by luteinizing hormone (LH), follicle‐stimulating hormone (FSH), and cAMP signaling. Conclusion CREM has a therapeutic role in maintaining testicular function, and its disruption may contribute to testiculopathy in T2D, highlighting its potential therapeutic target for preserving male fertility in diabetic patients. Further research is needed to explore its molecular mechanisms and therapeutic implications.
format Article
id doaj-art-1041de28cfcc40a180e97616d08537ff
institution Kabale University
issn 1445-5781
1447-0578
language English
publishDate 2025-01-01
publisher Wiley
record_format Article
series Reproductive Medicine and Biology
spelling doaj-art-1041de28cfcc40a180e97616d08537ff2025-08-20T06:16:47ZengWileyReproductive Medicine and Biology1445-57811447-05782025-01-01241n/an/a10.1002/rmb2.12661Potential Role of CREM in Diabetes‐Associated Testicular Dysfunction: Current Evidence and Future PerspectivesOlabimpe Caroline Badejogbin0Oyedayo Phillips Akano1Oluwafisayo Elizabeth Boluwatife Julius2Mary Olaoluwa Agunloye3Makinde Vincent Olubiyi4Ojichukwuka Ebere Chijioke‐Agu5Matthew Agene Obekpa6Adesina Paul Arikawe7Kehinde Samuel Olaniyi8Department of Physiology College of Basic Medical Sciences, Babcock University Ilishan‐Remo Ogun State NigeriaDepartment of Physiology College of Basic Medical Sciences, Babcock University Ilishan‐Remo Ogun State NigeriaDepartment of Physiology College of Basic Medical Sciences, Babcock University Ilishan‐Remo Ogun State NigeriaDepartment of Physiology Kampala International University, Western Campus Ishaka UgandaDepartment of Medical Physiology University of Rwanda Huye RwandaDepartment of Physiology Alex‐Ekwueme Federal University Abakaliki Ebonyi State NigeriaDepartment of Physiology University of Ilorin Ilorin Kwara State NigeriaDepartment of Physiology College of Medicine, University of Lagos State Idi‐Araba Lagos State NigeriaDepartment of Physiology College of Medicine and Health Sciences, Afe Babalola University Ado‐Ekiti Ekiti State NigeriaABSTRACT Background Type 2 diabetes mellitus (T2D) is a growing metabolic disorder affecting all age groups and is linked to testiculopathy, a key contributor to male infertility. Testiculopathy disrupts spermatogenesis and the sperm microenvironment, with the cyclic adenosine monophosphate (cAMP) response element modulator (CREM) playing a pivotal role in testicular function. Understanding the interplay between T2D and CREM dysregulation is essential for developing targeted therapies for diabetic testicular dysfunction. Methods A systematic review of PubMed, Web of Science, Scopus, and Google Scholar was conducted to identify peer‐reviewed studies, both preclinical and clinical, that explored CREM's role in diabetes‐induced testicular dysfunction. Extracted data focused on CREM expression, oxidative stress, apoptosis, and spermatogenic impairment in diabetic models. Main Findings Research from studies on diabetic patients and animal models highlights the detrimental effects of diabetes on the reproductive system, including hypothalamic–pituitary–testicular (HPT) axis dysregulation. CREM regulates spermatogenic gene expression, influenced by luteinizing hormone (LH), follicle‐stimulating hormone (FSH), and cAMP signaling. Conclusion CREM has a therapeutic role in maintaining testicular function, and its disruption may contribute to testiculopathy in T2D, highlighting its potential therapeutic target for preserving male fertility in diabetic patients. Further research is needed to explore its molecular mechanisms and therapeutic implications.https://doi.org/10.1002/rmb2.12661CREMmale infertilityreproductionspermatogenesistesticulopathytype 2 diabetes mellitus
spellingShingle Olabimpe Caroline Badejogbin
Oyedayo Phillips Akano
Oluwafisayo Elizabeth Boluwatife Julius
Mary Olaoluwa Agunloye
Makinde Vincent Olubiyi
Ojichukwuka Ebere Chijioke‐Agu
Matthew Agene Obekpa
Adesina Paul Arikawe
Kehinde Samuel Olaniyi
Potential Role of CREM in Diabetes‐Associated Testicular Dysfunction: Current Evidence and Future Perspectives
Reproductive Medicine and Biology
CREM
male infertility
reproduction
spermatogenesis
testiculopathy
type 2 diabetes mellitus
title Potential Role of CREM in Diabetes‐Associated Testicular Dysfunction: Current Evidence and Future Perspectives
title_full Potential Role of CREM in Diabetes‐Associated Testicular Dysfunction: Current Evidence and Future Perspectives
title_fullStr Potential Role of CREM in Diabetes‐Associated Testicular Dysfunction: Current Evidence and Future Perspectives
title_full_unstemmed Potential Role of CREM in Diabetes‐Associated Testicular Dysfunction: Current Evidence and Future Perspectives
title_short Potential Role of CREM in Diabetes‐Associated Testicular Dysfunction: Current Evidence and Future Perspectives
title_sort potential role of crem in diabetes associated testicular dysfunction current evidence and future perspectives
topic CREM
male infertility
reproduction
spermatogenesis
testiculopathy
type 2 diabetes mellitus
url https://doi.org/10.1002/rmb2.12661
work_keys_str_mv AT olabimpecarolinebadejogbin potentialroleofcremindiabetesassociatedtesticulardysfunctioncurrentevidenceandfutureperspectives
AT oyedayophillipsakano potentialroleofcremindiabetesassociatedtesticulardysfunctioncurrentevidenceandfutureperspectives
AT oluwafisayoelizabethboluwatifejulius potentialroleofcremindiabetesassociatedtesticulardysfunctioncurrentevidenceandfutureperspectives
AT maryolaoluwaagunloye potentialroleofcremindiabetesassociatedtesticulardysfunctioncurrentevidenceandfutureperspectives
AT makindevincentolubiyi potentialroleofcremindiabetesassociatedtesticulardysfunctioncurrentevidenceandfutureperspectives
AT ojichukwukaeberechijiokeagu potentialroleofcremindiabetesassociatedtesticulardysfunctioncurrentevidenceandfutureperspectives
AT matthewageneobekpa potentialroleofcremindiabetesassociatedtesticulardysfunctioncurrentevidenceandfutureperspectives
AT adesinapaularikawe potentialroleofcremindiabetesassociatedtesticulardysfunctioncurrentevidenceandfutureperspectives
AT kehindesamuelolaniyi potentialroleofcremindiabetesassociatedtesticulardysfunctioncurrentevidenceandfutureperspectives